PPARG and metabolic disease: Moreover, with its interesting pharmacological profile, lesinurad might also hold great therapeutic potential in metabolic diseases since adipogenic effects of PPARγ activation and resulting weight gain are a major obstacle to the therapeutic exploitation of PPARγ in metabolic diseases.